All Insights

COP27

COP26 | Energy Day

Welcome to the fourth instalment of our daily COP26 updates: a digest of what is on the agenda each day
Sustainable disruption: 12 decarbonising technologies for cities

Can sustainable disruption and technology deliver decarbonised cities?

Against the backdrop of COP26, the reduction of carbon emissions in cities and identifying methodology, technology and investment to achieve
COP27

COP26 | World Leaders' Summit begins

Welcome to the first instalment of our daily COP26 updates: a digest of what is on the agenda each day
Life Sciences and Healthcare

EUIPO trade mark decision makes protection for medical devices harder to achieve

Boehringer's EU shape trade mark for its HandiHaler declared invalid for performing a technical function
Sustainable disruption: 12 decarbonising technologies for cities

Sustainable disruption: 12 decarbonising technologies for cities

New research by Economist Impact , supported by Osborne Clarke, has identified 12 technologies that can help cities achieve their
Life Sciences and Healthcare

UK sets out plans to diverge from EU regime on gene editing in plants

The government has signalled its intention to pave the way for gene-edited crops following a consultation on departing from EU

Life Sciences and Healthcare

The government has vision for the UK as the world's leading hub for life sciences

Details on the funding of the 10-year strategy, which builds on the UK's world-class capability and on lessons from the

Hemp tea - the fine line between food and narcotics

The first article from our series "Cannabis - the 'green gold' from a legal perspective"

Life Sciences and Healthcare

Debate intensifies over a vaccine IP waiver's impact on future pharma and biotech discoveries

Does a proposed patent suspension backed by Washington open a Pandora's box for vaccine R&D and investment?

Life Sciences and Healthcare

Queen's Speech 2021 sets out ambitious agenda for UK life sciences and healthcare

New parliamentary term will be packed with legislation for life sciences and healthcare businesses

Life Sciences and Healthcare

Patents Court upholds validity of second medical use patent for glaucoma treatment

This decision shows the court assessing patentability in a real-world practical context, recognising the uncertainties of R&D that only later